Company / Working Capital
Eloxx Pharmaceuticals, Inc. Working Capital History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$21.1M
FY2025
5-year range
-$21.1M / $5.4M
FY2021-FY2025
Trend
-3546.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital changed -3547% YoY in FY2025, a notable deviation from the 3-year average annual change of -1224%.
Based on SEC 10-K filings.
-$21M in FY2025.
Declined from $3M to -$21M over the past 10 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Eloxx Pharmaceuticals, Inc.'s working capital has declined for 3 consecutive years.
- In FY2025, working capital decreased 3546.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$21.1M | -3546.5% |
| FY2016 | $613.6K | -79.2% |
| FY2015 | $3.0M | -45.3% |
| FY2014 | $5.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026